However, SIT treatment significantly reduced the expression of JNK1, IKKβ and NF-κB in type-2 diabetic rats, which in turn is suggestive of its potential to attenuate obesity induced inflammation and insulin resistance. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.